Octagam (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Octagam, is an immunoglobulin presented as a solution for intravenous use. It replaces deficient antibodies and is used in immune deficiencies and certain autoimmune conditions in both adults and children.

GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Octagam is an immunoglobulin therapy that modifies immune system activity in several clinical settings. - Primary immunodeficiency diseases: provides replacement antibodies to reduce infection frequency. - Chronic inflammatory demyelinating polyneuropathy (CIDP): helps restore nerve function and lessen disability. - Multifocal motor neuropathy (MMN): improves muscle strength and reduces relapse rates.

Adverse reactions to Octagam vary with the route of administration and patient factors.

Common Side Effects: - Headache: mild to moderate, often transient. - Fever or chills: typically occurs during or shortly after infusion. - Nausea or vomiting: mild gastrointestinal upset. - Fatigue: general tiredness post‑infusion. - Muscle aches: transient myalgia. - Injection site erythema: localized redness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Acute renal failure: sudden loss of kidney function, especially with high‑dose regimens. - Thromboembolic events: blood clots that may lead to stroke or pulmonary embolism. - Hemolytic anemia: destruction of red blood cells. - Aseptic meningitis: inflammation of the meninges without infection. - Severe hypotension: marked drop in blood pressure during infusion.

Before initiating Octagam therapy, clinicians should assess patient history and monitor for specific risks. - Renal function assessment: evaluate baseline creatinine and adjust infusion rate if impaired. - Thrombotic risk evaluation: consider history of clotting disorders before treatment. - Pregnancy and lactation counseling: discuss limited data and potential risks. - Concomitant immunosuppressants: monitor for additive immunosuppression. - Infusion rate management: start slowly and increase gradually to minimise reactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Octagam may interact with other medicines that affect immune function or renal clearance.

Major Interactions (Avoid): - Live vaccines: risk of reduced vaccine efficacy or severe infection. - High‑dose aspirin or NSAIDs: increased bleeding risk during infusion.

Moderate Interactions (Monitor Closely): - Nephrotoxic drugs (e.g., aminoglycosides): may worsen renal impairment. - Anticoagulants (e.g., warfarin): monitor INR and adjust dose as needed. - Corticosteroids: may augment immunosuppressive effect. - Diuretics: watch for fluid balance changes during infusion. - ACE inhibitors: monitor blood pressure for additive hypotensive effect.